Cipla share price has risen by 10% over the past 12 months and 64% over the last three years. The company's current market ...
Recce Pharmaceuticals has wrapped up dosing of all patients in its phase II clinical trial of its topical gel treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback